Small Cell Lung Cancer Extensive Stage Clinical Trials

ReadTheTrial indexes 2 studies for Small Cell Lung Cancer Extensive Stage. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Small Cell Lung Cancer Extensive Stage.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials for Small Cell Lung Cancer Extensive Stage

A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer

NCT07227597 · RECRUITING · Phase 2

Sequential Maintenance With Thoracic Radiotherapy and Durvalumab (MEDI4736) Monotherapy or Durvalumab (MEDI 4736) Combinations (Tremelimumab or Olaparib) in Patients With Extensive Stage-Small Cell Lung Cancer After First Line Platinum Based Chemotherapy

NCT03923270 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Small Cell Lung Cancer Extensive Stage?

There are 2 clinical trials listed for Small Cell Lung Cancer Extensive Stage. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Small Cell Lung Cancer Extensive Stage trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Small Cell Lung Cancer Extensive Stage trials in?

Current Small Cell Lung Cancer Extensive Stage trials are distributed across: Phase 2 (1), Phase 1 (1).

Find More Trials